PT  - JOURNAL ARTICLE
AU  - Saey Sofie
AU  - Piette Yves
AU  - Verstraete Barbara
AU  - Lambert Margareta
AU  - Van Hoeyweghen Raf
AU  - Vandekerckhove Bruno
AU  - Haspeslagh Marc
AU  - Grootaert Veerle
TI  - Building for better bones: evaluation of a clinical pathway in the secondary prevention of osteoporotic fractures
AID  - 10.1136/ejhpharm-2016-000906
DP  - 2018 Jul 01
TA  - European Journal of Hospital Pharmacy
PG  - 210--213
VI  - 25
IP  - 4
4099  - http://ejhp.bmj.com/content/25/4/210.short
4100  - http://ejhp.bmj.com/content/25/4/210.full
SO  - Eur J Hosp Pharm2018 Jul 01; 25
AB  - Objective Osteoporosis is a common disease that is underdiagnosed and undertreated. A multidisciplinary intervention may improve the identification and treatment of osteoporosis and may consequently prevent secondary fractures.Method Retrospective, single-centre study comparing attitude to screening and treatment of patients admitted to the orthopaedic unit of the general hospital AZ Sint-Jan Brugge-Oostende AV (Belgium) before and after the implementation of a clinical pathway.Results A total of 172 patients (86 before and 86 after) were included in this study. The implementation of the pathway resulted in an increase in bone mineral density tests performed, an increment in the number of referrals to a specialist in the field of osteoporosis, and an increase in prevention and treatment of osteoporosis.Conclusion The implementation of a clinical pathway coordinated and evaluated by a clinical pharmacist improved the identification, referral and treatment of osteoporosis in patients hospitalised due to low-impact fractures.